Aarti Drugs Ltd vs Gufic Biosciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Aarti Drugs Ltd is ₹ 365.2 as of 18 May 15:30 . The P/E Ratio of Aarti Drugs Ltd changed from 23.3 on March 2024 to 18.8 on March 2023 . This represents a CAGR of -4.20% over 5 yearsThe P/E Ratio of Gufic BioSciences Ltd changed from 33 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 years The Market Cap of Aarti Drugs Ltd changed from ₹ 3988 crore on March 2024 to ₹ 3128 crore on March 2023 . This represents a CAGR of -4.74% over 5 yearsThe Market Cap of Gufic BioSciences Ltd changed from ₹ 2839 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 years The revenue of Aarti Drugs Ltd for the Mar '26 is ₹ 721.06 crore as compare to the Dec '25 revenue of ₹ 602.94 crore. This represent the growth of 19.59% The revenue of Gufic BioSciences Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 232.2 crore. This represent the decline of -100% The ebitda of Aarti Drugs Ltd for the Mar '26 is ₹ 96.56 crore as compare to the Dec '25 ebitda of ₹ 56.26 crore. This represent the growth of 71.63% The ebitda of Gufic BioSciences Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 33.77 crore. This represent the decline of -100% The net profit of Aarti Drugs Ltd changed from ₹ 33.27 crore to ₹ 55.26 crore over 8 quarters. This represents a CAGR of 28.88% The net profit of Gufic BioSciences Ltd changed from ₹ 20.86 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Aarti Drugs Ltd changed from 9.04 % on March 2021 to 5.8 % on March 2025 . This represents a CAGR of -8.49% over 5 yearsThe Dividend Payout of Gufic BioSciences Ltd changed from 2.19 % on March 2021 to 1.43 % on March 2025 . This represents a CAGR of -8.17% over 5 years .

About Aarti Drugs Ltd

Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals.
The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million.
With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs.
Company also operates Pinnacle Life Science Private Limited, its wholly owned subsidiary focused on formulation development. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra.
It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary).

About Gufic BioSciences Ltd

Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients.
Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network.
The Company is ranked among the top 100 pharmaceutical companies in India. Gufic is a leading manufacturer of lyophilized injections in India, with a state-of-the-art automated lyophilization plant located in Navsari, Gujarat.
The Company was incorporated in July, 1984.
The recent addition of the Indore manufacturing facility has further solidified Gufic's position as one of the world's largest producers of lyophilized injections.

FAQs for the comparison of Aarti Drugs Ltd and Gufic BioSciences Ltd

Which company has a larger market capitalization, Aarti Drugs Ltd or Gufic BioSciences Ltd?

Market cap of Aarti Drugs Ltd is 3,333 Cr while Market cap of Gufic BioSciences Ltd is 2,797 Cr

What are the key factors driving the stock performance of Aarti Drugs Ltd and Gufic BioSciences Ltd?

The stock performance of Aarti Drugs Ltd and Gufic BioSciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarti Drugs Ltd and Gufic BioSciences Ltd?

As of May 18, 2026, the Aarti Drugs Ltd stock price is INR ₹365.2. On the other hand, Gufic BioSciences Ltd stock price is INR ₹278.95.

How do dividend payouts of Aarti Drugs Ltd and Gufic BioSciences Ltd compare?

To compare the dividend payouts of Aarti Drugs Ltd and Gufic BioSciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.